Literature DB >> 29076211

What is the best size predictor for dose in the obese child?

Brian J Anderson1, Nick Hg Holford2.   

Abstract

Lean body mass is commonly proposed for anesthesia maintenance drug dosing calculations. However, total body mass used with allometric scaling has been shown to be better for propofol in obese adults and children. Fat-free mass has also been used instead of lean body mass. Fat-free mass is essentially the same as lean body mass but excludes a small percentage of mass of lipids in cell membranes, CNS, and bone marrow. Normal fat mass is a size descriptor that partitions total body mass into fat-free mass and fat mass calculated from total body mass minus fat-free mass. The relative influence of fat mass compared with fat-free mass is described by the fraction of fat mass that makes fat equivalent to fat-free mass in terms of allometric size. This fraction (Ffat) will differ for each drug and each parameter affected by body size (eg, clearance and volume of distribution). This fraction is based on the concept of theory-based allometric size. The normal fat mass based on allometric theory and partition of body mass into fat and fat-free components provides a principle-based approach explaining size and body composition effects on pharmacokinetics of all drugs in children and in adults.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  dosing; fat-free mass; lean body weight; normal fat mass; obesity; pediatrics; pharmacokinetics; theory-based allometry

Mesh:

Substances:

Year:  2017        PMID: 29076211     DOI: 10.1111/pan.13272

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  8 in total

Review 1.  Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children.

Authors:  Kathryn E Kyler; Jonathan Wagner; Chelsea Hosey-Cojocari; Kevin Watt; Valentina Shakhnovich
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 2.  Prescribing drugs to overweight and obese children: Balancing efficacy and safety.

Authors:  Helene Roy; Christel Bertoldi; Catherine Farrell; Elisabeth Rousseau
Journal:  Paediatr Child Health       Date:  2021-01-21       Impact factor: 2.253

Review 3.  Pharmacokinetic Pharmacodynamic Modelling Contributions to Improve Paediatric Anaesthesia Practice.

Authors:  James D Morse; Luis Ignacio Cortinez; Brian J Anderson
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

4.  Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimates.

Authors:  Mario González-Sales; Nick Holford; Guillaume Bonnefois; Julie Desrochers
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-05       Impact factor: 2.745

5.  Population Pharmacokinetic Modelling of Acetaminophen and Ibuprofen: the Influence of Body Composition, Formulation and Feeding in Healthy Adult Volunteers.

Authors:  James D Morse; Ioana Stanescu; Hartley C Atkinson; Brian J Anderson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-04-02       Impact factor: 2.569

Review 6.  Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review.

Authors:  Claudia D'Alessandro; Alessia Benedetti; Antonello Di Paolo; Domenico Giannese; Adamasco Cupisti
Journal:  Nutrients       Date:  2022-01-04       Impact factor: 5.717

7.  Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.

Authors:  Khalil Ben Hassine; Tiago Nava; Yves Théoret; Christa E Nath; Youssef Daali; Nastya Kassir; Victor Lewis; Robbert G M Bredius; Peter J Shaw; Henrique Bittencourt; Maja Krajinovic; Chakradhara Rao Satyanarayana Uppugunduri; Marc Ansari
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-08-28

Review 8.  Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations.

Authors:  Jacqueline G Gerhart; Stephen Balevic; Jaydeep Sinha; Eliana M Perrin; Jian Wang; Andrea N Edginton; Daniel Gonzalez
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.